Loading...
XJSE
AIP
Market cap743mUSD
Nov 04, Last price  
7,480.00ZAR
Name

Adcock Ingram Holdings Ltd

Chart & performance

D1W1MN
XJSE:AIP chart
P/E
13.98
P/S
1.23
EPS
5.35
Div yield, %
3.68%
Shrs. gr., 5y
-2.43%
Rev. gr., 5y
5.85%
Revenues
Net income
CFO
Dividend
Sep 17, 2025165 ZAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Adcock Ingram Holdings Limited, established in 1890 and headquartered in Midrand, South Africa, operates as a global manufacturer, marketer, and distributor of diverse healthcare products. Its international footprint extends across South Africa, the United States, Canada, the United Kingdom, broader Europe, and other international regions. The company offers a comprehensive product portfolio, including over-the-counter (OTC) remedies, prescription medications, consumer health goods, and specialized medical instrumentation and surgical supplies. Its extensive pharmaceutical range covers numerous therapeutic classes, such as women's health, cannabidiol applications, antiretroviral treatments, dermatology, central nervous system disorders, respiratory conditions, ophthalmology, generic medicines, cardiovascular health, pain relief, gastroenterology, energy and immunity support (including colds and flu remedies, vitamins, minerals, and food/nutrition supplements), personal care, feminine hygiene, digestive well-being, allergy management, baby care, and cough solutions. Beyond its general healthcare offerings, Adcock Ingram also manufactures and supplies essential hospital and critical care products, such as intravenous solutions, renal dialysis systems, and blood collection supplies. The company serves both private and public sectors within the healthcare industry.
IPO date
Aug 25, 2008
Employees
Domiciled in
ZA
Incorporated in
ZA

Valuation

No data to show